Palantir to report; Trump on Nvidia chip exports - what’s moving markets
Investing.com -- Healthcare products manufacturer and distributor Medline Inc. has filed for an initial public offering, the company announced Monday.
The Northfield, Illinois-based company submitted a registration statement on Form S-1 with the Securities and Exchange Commission and plans to list its shares on the Nasdaq Global Select Market under the ticker symbol "MDLN" if the offering is completed.
Medline reported net sales of $6.89 billion for the three months ended June 28, 2025, with a quarterly net income of $333 million, according to the SEC filing.
The company has not yet determined the number of shares to be offered, price range, or other terms. The offering remains subject to market conditions and SEC approval, with no guarantee regarding timing or completion.
Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan will serve as lead bookrunning managers for the proposed offering.
This IPO represents a potential return to public markets for Medline, which was taken private in a $34 billion deal in 2021 by a consortium including Blackstone, Carlyle, and Hellman & Friedman.
The SEC filing showed that Blackstone and Carlyle are still among Medline’s principal stockholders.